Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Motor Therapy”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Testing effectiveness (Phase 2)Ended earlyNCT01766336
What this trial is testing

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 296
Not applicableLooking for participantsNCT07088055
What this trial is testing

Trial to Compare the Effects of Myo Munchee Therapy and Oral Motor Therapy (OMT) in Pediatric Patients to Treat Maxillary Deficiency and Orofacial Myofunctional Dysfunction (OMD).

Who this might be right for
Orofacial Myofunctional DisordersMyo MuncheeOral Motor Therapy+1 more
Myo Munchee (Operations) Pty Ltd 48
Not applicableStudy completedNCT05099107
What this trial is testing

Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment

Who this might be right for
Congenital MyopathyNeuromuscular DiseasesMusculoskeletal Diseases+3 more
Vastra Gotaland Region 18
Large-scale testing (Phase 3)Study completedNCT00125203
What this trial is testing

Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisSialorrhea
The University of Texas Health Science Center at San Antonio 20
Testing effectiveness (Phase 2)Study completedNCT00877604
What this trial is testing

Efficacy and Tolerability of Tauroursodeoxycholic Acid in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 34
Not applicableStudy completedNCT04665973
What this trial is testing

Effect of an Oral Therapeutic Patient Education Session on Physical Activity in Patients With Cancer

Who this might be right for
Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 98
Not applicableStudy completedNCT01420796
What this trial is testing

Swallowing and Breathing Exercises for Dysphagia in Parkinson Disease

Who this might be right for
Parkinson DiseaseDysphagia
Federal University of Bahia 38
Not applicableLooking for participantsNCT06467136
What this trial is testing

Motor Imagery for Treatment Enhancement and Efficacy in Persons With Apraxia of Speech

Who this might be right for
Apraxia, OralApraxia of Speech
University of Central Florida 18
Large-scale testing (Phase 3)Study completedNCT00199407
What this trial is testing

Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

Who this might be right for
Parkinson's Disease
Kyowa Kirin, Inc. 230
Large-scale testing (Phase 3)Study completedNCT04380142
What this trial is testing

Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)
AbbVie 174
Not applicableUnknownNCT05707091
What this trial is testing

Low Laser Therapy on Facial Motor Functions Function and Synkinesis in Patients With Bell's Palsy

Who this might be right for
Bell's Palsy
Riphah International University 32
Post-approval studies (Phase 4)Study completedNCT00297778
What this trial is testing

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms

Who this might be right for
Parkinson DiseaseDepression
Boehringer Ingelheim 296
Not applicableStudy completedNCT05792709
What this trial is testing

Effects of Oral Motor Therapy in Children With Cerebral Palsy

Who this might be right for
Cerebral Palsy
Riphah International University 10
Testing effectiveness (Phase 2)WithdrawnNCT03331848
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED)

Who this might be right for
Parkinson Disease
Prexton Therapeutics
Not applicableStudy completedNCT02333981
What this trial is testing

Efficacy of Passive Oral Motor Therapy on Drooling in Children With Multiple Disabilities

Who this might be right for
Multiple Disabilities
Maharishi Markendeswar University (Deemed to be University) 7
Large-scale testing (Phase 3)Study completedNCT00199368
What this trial is testing

An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018

Who this might be right for
Parkinson's Disease
Kyowa Kirin, Inc. 1,100
Not applicableStudy completedNCT04102306
What this trial is testing

Assessing Motor Imagery Ability of Tongue and Mouth in Subjects With and With no Temporomandibular Disorders

Who this might be right for
Temporomandibular DisorderMotor Imagery
Cabinet de Kinesitherapie SCM Saint-Alexandre 94
Testing effectiveness (Phase 2)Looking for participantsNCT06808984
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Who this might be right for
AgitationAlzheimer Disease
Celgene 120
Large-scale testing (Phase 3)Study completedNCT00408915
What this trial is testing

Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion

Who this might be right for
Parkinson's Disease
Axxonis Pharma AG 60
Large-scale testing (Phase 3)WithdrawnNCT02782481
What this trial is testing

A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations

Who this might be right for
Parkinson's Disease
NeuroDerm Ltd.
Load More Results